208 pill
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS
6.2 Post marketing Experience
The following adverse reactions have been identified during postapproval use of citalopram, the racemate, or escitalopram, the S-enantiomer of citalopram. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or confirm a causal relationship to drug exposure.
Blood and Lymphatic System Disorders: hemolytic anemia, thrombocytopenia, prothrombin decreased.
Cardiac Disorders: torsade de pointes, ventricular arrhythmia, QT prolonged
Endocrine Disorders: hyperprolactinemia
Eye Disorders: angle-closure glaucoma
Gastrointestinal Disorders: gastrointestinal hemorrhage, pancreatitis
General Disorders and Administrative Site Conditions: withdrawal syndrome
Hepatobiliary Disorders: hepatic necrosis
Immune System Disorders: anaphylaxis, allergic reaction
Musculoskeletal and Connective Tissue Disorders: rhabdomyolysis
Nervous System Disorders: grand mal convulsion(s), myoclonus, choreoathetosis, dyskinesia, akathisia, nystagmus
Pregnancy, Puerperium and Perinatal Conditions: spontaneous abortion
Psychiatric D
Pill Imprint I G 208
This medicine is known as citalopram. It is available as a prescription only medicine and is commonly used for Agitation, Anxiety and Force, Bipolar Disorder, Body Dysmorphic Disorder, Borderline Personality Disorder, Depression, Dissociative Identity Disorder, Excoriation Disorder, Generalized Anxiety Disorder, Scorching Flashes, Neuralgia, Obsessive Compulsive Disorder, Occipital Neuralgia, Panic Disorder, Persistent Depressive Disorder, Postpartum Depression, Premenstrual Dysphoric Disorder, Grave Mood Dysregulation, Somatoform Pain Disorder, Trichotillomania, Vulvodynia.
Details for pill imprint I G 208
- Drug
- Citalopram
- Imprint
- I G 208
- Strength
- 40 mg
- Color
- White
- Shape
- Round
- Size
- 10mm
- Availability
- Prescription only
Pill Classification
- National Drug Code (NDC)
- 690970824
Care Well 4 In 1 Pill Container Cw 208
Always search the advice of your physician or health care provider with any questions you may contain regarding a medical condition or treatment and before undertaking a new health care regimen.
It is recommended that you verify the more detailed information in relation to the product upon physical receipt before use.
This would include information on matters such as most complete and up-to-date list of ingredients, proper application, potential side-effects, ingredients and any application/usage guidelines or warnings.
we accept no liability for injure resulting from the misuse products or improper storage
You have the right to ask prior to purchase, In the event you have any queries or concerns in relation to the product please contact us on 800500800
WARNING: POTENTIAL RISK FOR CARCINOGENICITY
6.2 Postmarketing Experience
The following adverse reactions have been identified and reported during post-approval use of tinidazole tablets. Because the reports of these reactions are voluntary and the population is of uncertain size, it is not always possible to reliably estimate the frequency of the reaction or establish a causal relationship to drug exposure.
Tinidazole Tablets:
Severe acute hypersensitivity reactions have been reported on initial or subsequent exposure to tinidazole. Hypersensitivity reactions may include urticaria, pruritis, angioedema, Stevens-Johnson syndrome and erythema multiforme.
Metronidazole, Another Nitroimidazole Product, Structurally Associated to Tinidazole:
Cases of severe irreversible hepatotoxicity/acute liver shortcoming, including cases with fatal outcomes with very rapid onset after initiation of systemic use of metronidazole, another nitroimidazole agent structurally connected to tinidazole, hold been reported in patients with Cockayne syndrome (latency from rug start to signs of liver failure as concise as 2 days) [see Contraindications (4)].